Segment Information

Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.

We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items.

The following table presents information about our reportable segments, reconciled to consolidated totals:



($ in millions)	2018			2017			2016
Net sales:
Proprietary Products	$	1,308.6		$	1,236.9		$	1,189.9
Contract-Manufactured Products	409.1			362.5			320.2
Intersegment sales elimination	(0.3		)	(0.3		)	(1.0		)
Consolidated net sales	$	1,717.4		$	1,599.1		$	1,509.1

The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.

We do not have any customers accounting for greater than 10% of consolidated net sales.

The following table presents net sales and property, plant and equipment, net, by the country in which the legal subsidiary is domiciled and assets are located:



	Net Sales						Property, Plant and Equipment, Net
($ in millions)	2018		2017		2016		2018		2017		2016
United States	$	766.1	$	734.6	$	738.3	$	315.3	$	323.8	$	329.3
Germany	235.9		226.4		200.6		99.3		108.8		96.8
France	127.5		125.6		116.3		42.5		43.1		37.1
Other European countries	386.1		318.5		268.3		232.5		244.9		192.3
Other	201.8		194.0		185.6		132.4		134.4		122.8
	$	1,717.4	$	1,599.1	$	1,509.1	$	822.0	$	855.0	$	778.3

The following tables provide summarized financial information for our segments:



($ in millions)	Proprietary Products		Contract-Manufactured Products		Corporate and Elimination			Consolidated
2018
Net sales	$	1,308.6	$	409.1	$	(0.3	)	$	1,717.4
Operating profit	$	266.4	$	44.3	$	(70.4	)	$	240.3
Interest expense	—		—		8.4			8.4
Interest income	—		—		(2.1		)	(2.1		)
Other nonoperating income	—		—		(6.7		)	(6.7		)
Income before income taxes	$	266.4	$	44.3	$	(70.0	)	$	240.7
Segment assets	$	1,342.3	$	301.4	$	335.2		$	1,978.9
Capital expenditures	77.0		20.7		7.0			104.7
Depreciation and amortization expense	83.9		17.2		3.3			104.4

2017
Net sales	$	1,236.9	$	362.5	$	(0.3	)	$	1,599.1
Operating profit	$	243.8	$	48.3	$	(66.3	)	$	225.8
Interest expense	—		—		7.8			7.8
Interest income	—		—		(1.3		)	(1.3		)
Other nonoperating income	—		—		(3.1		)	(3.1		)
Income before income taxes	$	243.8	$	48.3	$	(69.7	)	$	222.4
Segment assets	$	1,321.3	$	286.4	$	255.1		$	1,862.8
Capital expenditures	107.2		18.6		5.0			130.8
Depreciation and amortization expense	77.1		16.4		3.2			96.7

2016
Net sales	$	1,189.9	$	320.2	$	(1.0	)	$	1,509.1
Operating profit	$	243.1	$	38.2	$	(86.1	)	$	195.2
Interest expense	—		—		8.1			8.1
Interest income	—		—		(1.1		)	(1.1		)
Other nonoperating income	—		—		(1.6		)	(1.6		)
Income before income taxes	$	243.1	$	38.2	$	(91.5	)	$	189.8
Segment assets	$	1,173.9	$	261.1	$	281.7		$	1,716.7
Capital expenditures	133.2		34.0		3.0			170.2
Depreciation and amortization expense	71.7		14.9		4.1			90.7